2018Allergy and Asthma ProceedingsRequires access

Update on peanut allergy: Prevention and immunotherapy

Quindelyn Cook, Edwin Kim

Open publisher page 16 citations

Abstract

Advances in food immunotherapy have continued to push the field forward and provided a better understanding of the safety and efficacy of OIT, SLIT, and EPIT. These treatments remain experimental, although phase III studies are currently underway.

About this research paper

What this paper is about

Advances in food immunotherapy have continued to push the field forward and provided a better understanding of the safety and efficacy of OIT, SLIT, and EPIT. These treatments remain experimental, although phase III studies are currently underway.

Why it matters

OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Advances in food immunotherapy have continued to push the field forward and provided a better understanding of the safety and efficacy of OIT, SLIT, and EPIT. These treatments remain experimental, although phase III studies are currently underway.

Key concepts: Peanut allergy, Oral immunotherapy, Medicine, Desensitization (medicine), Food allergy, Allergy, Egg allergy, Sublingual immunotherapy

Related papers

Back to paper searchBrowse research topicsOriginal source
Update on peanut allergy: Prevention and immunotherapy — Research Paper | ScholarLens